Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 6/20 | 0.35 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | USP14 | P54578 | 1/20 | 0.33 |
| ▸ | CFD | P00746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20616921 | 0.98 | ATM (0.42) | KDM4EATML3MBTL1PTGER4PGR | |
| SCHEMBL17034464 | 0.95 | KDM4E (0.37) | KDM4EATML3MBTL1PTGER4RORC | |
| SCHEMBL17032723 | 0.94 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4RORC | |
| SCHEMBL15250654 | 0.94 | KDM4E (0.44) | KDM4EATML3MBTL1PTGER4PGR | |
| SCHEMBL18623541 | 0.94 | KDM4E (0.44) | KDM4EATML3MBTL1PTGER4PGR | |
| SCHEMBL18698248 | 0.94 | KDM4E (0.40) | KDM4EATML3MBTL1PTGER4PGR | |
| SCHEMBL17034476 | 0.93 | KDM4E (0.39) | KDM4EATML3MBTL1PTGER4RORC | |
| SCHEMBL21984920 | 0.93 | ATM (0.46) | KDM4EATML3MBTL1PTGER4PGR | |
| SCHEMBL21984906 | 0.93 | ATM (0.46) | KDM4EATML3MBTL1PTGER4PGR | |
| SCHEMBL18698249 | 0.93 | ATM (0.46) | KDM4EATML3MBTL1PTGER4PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3569605-A1 | NOVEL ELECTROLUMINESCENT METAL COMPLEXES AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2019-11-20 | — | — | EP | disclosed |
| EP-3150606-B1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLES CARRYING BENZOFURANE OR BENZOTHIOPHENE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO (JP) | 2019-08-14 | — | — | EP | disclosed |
| US-20190006601-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICES CONTAINING THEM | IDEMITSU KOSAN CO., LTD. (JP) | 2019-01-03 | — | — | US | disclosed |
| EP-3150604-A1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLYL GROUPS, CARBAZOLYL GROUPS, BENZOFURANE GROUPS OR BENZOTHIOPHENE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO., LTD. (JP) | 2017-04-05 | — | — | EP | disclosed |
| EP-3150606-A1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLES CARRYING BENZOFURANE OR BENZOTHIOPHENE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO., LTD. (JP) | 2017-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190006601-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICES CONTAINING THEM | SLC39A11, S100A11, SLC29A1 | KDM4E 4125/4885ATM 3977/4885L3MBTL1 3116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.